Advertisement
Screener

Tilray Brands, Inc. (TLRY) Proceeds from Long-term Lines of Credit

2.3 / 5 stars · 30/64 Roast Me

Tilray Brands, Inc. Proceeds from Long-term Lines of Credit

Tilray Brands, Inc. (TLRY) reported Proceeds from Long-term Lines of Credit of $29.17 million for the 3-month period ending 2023-08-31, per its 10-Q filed 2024-10-10.

Financial Statements › Cash Flow › Financing Activities

us-gaap:ProceedsFromLongTermLinesOfCredit · last filed 2024-10-10

  • Tilray Brands, Inc. proceeds from long-term lines of credit for the quarter ending 2023-08-31 was $29.17M, a 2165.06% increase year-over-year.
  • Tilray Brands, Inc. proceeds from long-term lines of credit for the quarter ending 2023-05-31 was $0.00.
  • Tilray Brands, Inc. proceeds from long-term lines of credit for the quarter ending 2023-02-28 was $0.00.
  • Tilray Brands, Inc. proceeds from long-term lines of credit for the quarter ending 2022-11-30 was $0.00.
  • Tilray Brands, Inc. proceeds from long-term lines of credit for fiscal 2023 was $1.29M.
  • Tilray Brands, Inc. proceeds from long-term lines of credit for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
  • Tilray Brands, Inc. proceeds from long-term lines of credit for fiscal 2021 was $102.80M, a 68.68% increase from fiscal 2020.
  • Tilray Brands, Inc. proceeds from long-term lines of credit for fiscal 2020 was $60.94M, a 189.48% increase from fiscal 2019.
Period endProceeds from Long-term Lines of Credit 3 monthProceeds from Long-term Lines of Credit 6 monthProceeds from Long-term Lines of Credit 9 monthProceeds from Long-term Lines of Credit 12 month
2023-08-31$29.17M
10-Q · filed 2024-10-10
$29.17M
derived: sum of 2 quarters · filed 2024-10-10
$29.17M
derived: sum of 3 quarters · filed 2024-10-10
$29.17M
derived: sum of 4 quarters · filed 2024-10-10
2023-05-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26
$0.00
derived: sum of 2 quarters · filed 2023-07-26
$0.00
derived: sum of 3 quarters · filed 2023-07-26
$1.29M
10-K · filed 2023-07-26
2023-02-28$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-10
$0.00
derived: sum of 2 quarters · filed 2023-04-10
$1.29M
10-Q · filed 2023-04-10
$1.29M
derived: sum of 4 quarters · filed 2024-10-10
2022-11-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09
$1.29M
10-Q · filed 2023-01-09
$1.29M
derived: sum of 3 quarters · filed 2024-10-10
$1.29M
derived: sum of 4 quarters · filed 2024-10-10
2022-08-31$1.29M
10-Q · filed 2024-10-10
$1.29M
derived: sum of 2 quarters · filed 2024-10-10
$1.29M
derived: sum of 3 quarters · filed 2024-10-10
$1.29M
derived: sum of 4 quarters · filed 2024-10-10
2022-05-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26
$0.00
derived: sum of 2 quarters · filed 2023-07-26
$0.00
derived: sum of 3 quarters · filed 2023-07-26
$0.00
10-K · filed 2023-07-26
2022-02-28$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-10
$0.00
derived: sum of 2 quarters · filed 2023-04-10
$0.00
10-Q · filed 2023-04-10
$0.00
derived: sum of 4 quarters · filed 2023-07-26
2021-11-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09
$0.00
10-Q · filed 2023-01-09
$0.00
derived: sum of 3 quarters · filed 2023-07-26
$100.92M
derived: sum of 4 quarters · filed 2023-07-26
2021-08-31$0.00
10-Q · filed 2022-10-07
$0.00
derived: sum of 2 quarters · filed 2023-07-26
$100.92M
derived: sum of 3 quarters · filed 2023-07-26
$100.91M
derived: sum of 4 quarters · filed 2023-07-26
2021-05-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26
$100.92M
derived: sum of 2 quarters · filed 2023-07-26
$100.91M
derived: sum of 3 quarters · filed 2023-07-26
$102.80M
10-K · filed 2023-07-26
2021-02-28$100.92M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-06
$100.91M
derived: sum of 2 quarters · filed 2022-04-06
$102.80M
10-Q · filed 2022-04-06
2020-11-30-$6.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-10
$1.88M
10-Q · filed 2022-01-10
2020-08-31$1.89M
10-Q · filed 2021-10-07
2020-05-31$60.94M
10-K · filed 2022-07-28
2019-05-31$21.05M
10-K · filed 2021-07-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87